The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Letter to the editor
Editor, – 'Disease modifying drugs in adult rheumatoid arthritis' (Aust Prescr 2003;26:36-40) is an informative article, however, I would appreciate comments on the therapeutic applications of beta-emitting radionuclides like Holmium-166.
Director, Centre for Nuclear Medicine & Ultrasound
Bangladesh Atomic Energy Commission, Rangpur-5400
- Heuft-Dorenbosch LL, de Vet HC, van der Linden S. Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic review. Ann Rheum Dis 2000;59:583-6.